Loading...

Cerus Corporation

CERS•NASDAQ
Healthcare
Medical - Devices
$1.36
$-0.03(-2.16%)

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.7/100

Key Financials

Market Cap260M
P/E Ratio-13.67
EPS (TTM)$-0.10
ROE-0.35%
Fundamental Analysis

AI Price Forecasts

1 Week$1.46
1 Month$1.46
3 Months$1.66
1 Year Target$1.24

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.67 and a market capitalization of 260M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;